LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling

• Hui-Wen Lue,

  Affiliation Department of Biology, Georgia State University, Atlanta, Georgia, United States of America

  ⨯
• Xiaojian Yang,

  Affiliations Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Department of Urology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China

  ⨯
• Ruoxiang Wang,

  Affiliation Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Weiping Qian,

  Affiliation Department of Urology, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Roy Z. H. Xu,

  Affiliation Department of Biostatistics, Emory University School of Public Health, Atlanta, Georgia, United States of America

  ⨯
• Robert Lyles,

  Affiliation Department of Biostatistics, Emory University School of Public Health, Atlanta, Georgia, United States of America

  ⨯
• Adeboye O. Osunkoya,

  Affiliation Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, United States of America

  ⨯
• Binhua P. Zhou,

  Affiliation The Sealy Center for Cancer Cell Biology, University of Texas Medical Branch, Galveston, Texas, United States of America

  ⨯
• Robert L. Vessella,

  Affiliation Department of Urology, University of Washington, Seattle, Washington, United States of America

  ⨯
• Majd Zayzafoon,

  Affiliation Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Zhi-Ren Liu,

  Affiliation Department of Biology, Georgia State University, Atlanta, Georgia, United States of America

  ⨯
• Haiyen E. Zhau ,

  * E-mail: leland.chung@cshs.org (LWKC); haiyen.zhau@cshs.org (HEZ)

  Affiliation Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Leland W. K. Chung

  * E-mail: leland.chung@cshs.org (LWKC); haiyen.zhau@cshs.org (HEZ)

  Affiliation Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯